<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34351016</PMID><DateCompleted><Year>2021</Year><Month>09</Month><Day>13</Day></DateCompleted><DateRevised><Year>2024</Year><Month>08</Month><Day>15</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1365-2222</ISSN><JournalIssue CitedMedium="Internet"><Volume>51</Volume><Issue>9</Issue><PubDate><Year>2021</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology</Title><ISOAbbreviation>Clin Exp Allergy</ISOAbbreviation></Journal><ArticleTitle>Incidence and risk factors for persistent symptoms in adults previously hospitalized for COVID-19.</ArticleTitle><Pagination><StartPage>1107</StartPage><EndPage>1120</EndPage><MedlinePgn>1107-1120</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/cea.13997</ELocationID><Abstract><AbstractText Label="BACKGROUND">The long-term sequalae of COVID-19&#xa0;remain poorly characterized. We assessed persistent symptoms in previously hospitalized patients with COVID-19 and assessed potential risk factors.</AbstractText><AbstractText Label="METHODS">Data were collected from patients discharged from 4&#xa0;hospitals in Moscow, Russia between 8 April and 10&#xa0;July 2020. Participants were interviewed via telephone using an ISARIC Long-term Follow-up Study questionnaire.</AbstractText><AbstractText Label="RESULTS">2,649 of 4755 (56%) discharged patients were successfully evaluated, at median 218 (IQR 200, 236) days post-discharge. COVID-19 diagnosis was clinical in 1291 and molecular in 1358. Most cases were mild, but 902 (34%) required supplemental oxygen and 68 (2.6%) needed ventilatory support. Median age was 56&#xa0;years (IQR 46, 66) and 1,353 (51.1%) were women. Persistent symptoms were reported by 1247 (47.1%) participants, with fatigue (21.2%), shortness of breath (14.5%) and forgetfulness (9.1%) the most common symptoms and chronic fatigue (25%) and respiratory (17.2%) the most common symptom categories. Female sex was associated with any persistent symptom category OR 1.83 (95% CI 1.55 to 2.17) with association being strongest for dermatological (3.26, 2.36 to 4.57) symptoms. Asthma and chronic pulmonary disease were not associated with persistent symptoms overall, but asthma was associated with neurological (1.95, 1.25 to 2.98) and mood and behavioural changes (2.02, 1.24 to 3.18), and chronic pulmonary disease was associated with chronic fatigue (1.68, 1.21 to 2.32).</AbstractText><AbstractText Label="CONCLUSIONS">Almost half of adults admitted to hospital due to COVID-19 reported persistent symptoms 6 to 8&#xa0;months after discharge. Fatigue and respiratory symptoms were most common, and female sex was associated with persistent symptoms.</AbstractText><CopyrightInformation>&#xa9; 2021 John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Munblit</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0001-9652-6856</Identifier><AffiliationInfo><Affiliation>Department of Paediatrics and Paediatric Infectious Diseases, Institute of Child's Health, Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Inflammation, Repair and Development Section, Faculty of Medicine, National Heart and Lung Institute, Imperial College London, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research and Clinical Center for Neuropsychiatry, Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bobkova</LastName><ForeName>Polina</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Paediatrics and Paediatric Infectious Diseases, Institute of Child's Health, Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spiridonova</LastName><ForeName>Ekaterina</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Paediatrics and Paediatric Infectious Diseases, Institute of Child's Health, Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shikhaleva</LastName><ForeName>Anastasia</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Paediatrics and Paediatric Infectious Diseases, Institute of Child's Health, Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gamirova</LastName><ForeName>Aysylu</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Paediatrics and Paediatric Infectious Diseases, Institute of Child's Health, Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blyuss</LastName><ForeName>Oleg</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Department of Paediatrics and Paediatric Infectious Diseases, Institute of Child's Health, Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Physics, Astronomy and Mathematics, University of Hertfordshire, Hatfield, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nekliudov</LastName><ForeName>Nikita</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Paediatrics and Paediatric Infectious Diseases, Institute of Child's Health, Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bugaeva</LastName><ForeName>Polina</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Paediatrics and Paediatric Infectious Diseases, Institute of Child's Health, Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Andreeva</LastName><ForeName>Margarita</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Paediatrics and Paediatric Infectious Diseases, Institute of Child's Health, Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>DunnGalvin</LastName><ForeName>Audrey</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-1540-3959</Identifier><AffiliationInfo><Affiliation>Department of Paediatrics and Paediatric Infectious Diseases, Institute of Child's Health, Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Applied Psychology, University College Cork, Cork City, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Comberiati</LastName><ForeName>Pasquale</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0001-5209-9733</Identifier><AffiliationInfo><Affiliation>Department of Clinical and Experimental Medicine, Section of Pediatrics, University of Pisa, Pisa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Apfelbacher</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Institute of Social Medicine and Health Systems Research, Faculty of Medicine, Otto von Guericke University Magdeburg, Magdeburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Genuneit</LastName><ForeName>Jon</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0001-5764-1528</Identifier><AffiliationInfo><Affiliation>Pediatric Epidemiology, Department of Pediatrics, Medical Faculty, Leipzig University, Leipzig, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Avdeev</LastName><ForeName>Sergey</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Clinic of Pulmonology, Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kapustina</LastName><ForeName>Valentina</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine &#x2116;1, Institute of Clinical Medicine, Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guekht</LastName><ForeName>Alla</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Research and Clinical Center for Neuropsychiatry, Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fomin</LastName><ForeName>Victor</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Svistunov</LastName><ForeName>Andrey A</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Timashev</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Institute for Regenerative Medicine, Sechenov First Moscow State Medical University (Sechenov University, Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Subbot</LastName><ForeName>Vladislav S</ForeName><Initials>VS</Initials><Identifier Source="ORCID">0000-0002-7834-7819</Identifier><AffiliationInfo><Affiliation>Department of Oncology, Radiotherapy and Plastic Surgery, University Clinical Hospital No 1, Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Royuk</LastName><ForeName>Valery V</ForeName><Initials>VV</Initials><AffiliationInfo><Affiliation>N.A. Semashko Department of Public Health and Healthcare, Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Drake</LastName><ForeName>Thomas M</ForeName><Initials>TM</Initials><AffiliationInfo><Affiliation>Centre for Medical Informatics, University of Edinburgh, Edinburgh, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hanson</LastName><ForeName>Sarah Wulf</ForeName><Initials>SW</Initials><AffiliationInfo><Affiliation>Institute for Health Metrics and Evaluation, University of Washington, Seattle, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Merson</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Nuffield Department of Medicine, ISARIC Global Support Centre, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carson</LastName><ForeName>Gail</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Nuffield Department of Medicine, ISARIC Global Support Centre, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Horby</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Nuffield Department of Medicine, ISARIC Global Support Centre, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sigfrid</LastName><ForeName>Louise</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Nuffield Department of Medicine, ISARIC Global Support Centre, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scott</LastName><ForeName>Janet T</ForeName><Initials>JT</Initials><AffiliationInfo><Affiliation>MRC-University of Glasgow Centre for Virus Research, Glasgow, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Semple</LastName><ForeName>Malcolm G</ForeName><Initials>MG</Initials><Identifier Source="ORCID">0000-0001-9700-0418</Identifier><AffiliationInfo><Affiliation>Health Protection Research Unit in Emerging and Zoonotic Infections, Institute of Infection, Veterinary and Ecological Sciences, Faculty of Health and Life Sciences, University of Liverpool, Liverpool, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Respiratory Medicine, Alder Hey Children's Hospital, Liverpool, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Warner</LastName><ForeName>John O</ForeName><Initials>JO</Initials><AffiliationInfo><Affiliation>Inflammation, Repair and Development Section, Faculty of Medicine, National Heart and Lung Institute, Imperial College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vos</LastName><ForeName>Theo</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Institute for Health Metrics and Evaluation, University of Washington, Seattle, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Olliaro</LastName><ForeName>Piero</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Nuffield Department of Medicine, ISARIC Global Support Centre, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Glybochko</LastName><ForeName>Petr</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Butnaru</LastName><ForeName>Denis</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>Sechenov StopCOVID Research Team</CollectiveName></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>MC_PC_19026</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MC_PC_19059</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>INT 2021/RSM C 19 01</GrantID><Agency>UK Embassy in Moscow</Agency><Country/></Grant><Grant><GrantID>MC_UU_12014/8</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>20-04-60063</GrantID><Agency>Russian Foundation for Basic Research</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016430">Clinical Trial</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>08</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Clin Exp Allergy</MedlineTA><NlmUniqueID>8906443</NlmUniqueID><ISSNLinking>0954-7894</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000359" MajorTopicYN="Y">Aftercare</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086742" MajorTopicYN="Y">COVID-19 Testing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="Y">Hospitalization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012426" MajorTopicYN="N" Type="Geographic">Russia</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="Y">Surveys and Questionnaires</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000093485" MajorTopicYN="Y">COVID-19 Drug Treatment</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">PASC</Keyword><Keyword MajorTopicYN="N">asthma</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">post-COVID Condition</Keyword><Keyword MajorTopicYN="N">post-COVID Syndrome</Keyword><Keyword MajorTopicYN="N">postacute sequelae SARS-CoV-2 infection</Keyword><Keyword MajorTopicYN="N">risk factors</Keyword></KeywordList><CoiStatement>J. Genuneit reports working as a project manager of unrestricted research grants on the composition of breast milk to the Ulm University and Leipzig University. M.G. Semple reports grants from DHSC National Institute of Health Research UK, grants from Medical Research Council UK, grants from Health Protection Research Unit in Emerging &amp; Zoonotic Infections, University of Liverpool outside the submitted work; he also reports a minority ownership at Integrum Scientific LLC, Greensboro, NC, USA outside the submitted work. T. Vos reports personal fees for work on Global Burden of Disease Study from Bill and Melinda Gates Foundation, outside the submitted work. All other authors report no relevant conflict of interests.</CoiStatement><InvestigatorList><Investigator ValidYN="Y"><LastName>Abdeeva</LastName><ForeName>Elina</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Alekseeva</LastName><ForeName>Nikol</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Antsiferova</LastName><ForeName>Elena</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Artigas</LastName><ForeName>Elena</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bairashevskaia</LastName><ForeName>Anastasiia</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Belkina</LastName><ForeName>Anna</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bezrukov</LastName><ForeName>Vadim</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bordyugov</LastName><ForeName>Semyon</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bratukhina</LastName><ForeName>Maria</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chen</LastName><ForeName>Jessica</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Deunezhewa</LastName><ForeName>Salima</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Elifkhanova</LastName><ForeName>Khalisa</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ezhova</LastName><ForeName>Anastasia</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Filippova</LastName><ForeName>Yulia</ForeName><Initials>Y</Initials></Investigator><Investigator ValidYN="Y"><LastName>Frolova</LastName><ForeName>Aleksandra</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ganieva</LastName><ForeName>Julia</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gorina</LastName><ForeName>Anastasia</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kalan</LastName><ForeName>Yulia</ForeName><Initials>Y</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kirillov</LastName><ForeName>Bogdan</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Korgunova</LastName><ForeName>Mariia</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Krupina</LastName><ForeName>Alexandra</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kuznetsova</LastName><ForeName>Anna</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Listovskaia</LastName><ForeName>Ekaterina</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mikheeva</LastName><ForeName>Margarita</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mursalova</LastName><ForeName>Aigun</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ogandzhanova</LastName><ForeName>Marina</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Parr</LastName><ForeName>Callum</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rumyantsev</LastName><ForeName>Mikhail</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Smirnov</LastName><ForeName>Denis</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Shishkina</LastName><ForeName>Nataliya</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>El-Taravi</LastName><ForeName>Yasmin</ForeName><Initials>Y</Initials></Investigator><Investigator ValidYN="Y"><LastName>Varaksina</LastName><ForeName>Maria</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vodianova</LastName><ForeName>Maria</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zezyulina</LastName><ForeName>Anna</ForeName><Initials>A</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>6</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>7</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>8</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>9</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>8</Month><Day>5</Day><Hour>8</Hour><Minute>53</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>8</Month><Day>12</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34351016</ArticleId><ArticleId IdType="pmc">PMC8444748</ArticleId><ArticleId IdType="doi">10.1111/cea.13997</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Dong E, Du H, Gardner L. An interactive web&#x2010;based dashboard to track COVID&#x2010;19 in real time. Lancet Infect Dis. 2020;20(5):533&#x2010;534.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7159018</ArticleId><ArticleId IdType="pubmed">32087114</ArticleId></ArticleIdList></Reference><Reference><Citation>Docherty AB, Harrison EM, Green CA, et al. Features of 20 133 UK patients in hospital with covid&#x2010;19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study. BMJ. 2020;369:m1985.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7243036</ArticleId><ArticleId IdType="pubmed">32444460</ArticleId></ArticleIdList></Reference><Reference><Citation>Munblit D, Nekliudov NA, Bugaeva P, et al. StopCOVID cohort: an observational study of 3,480 patients admitted to the Sechenov University hospital network in Moscow city for suspected COVID&#x2010;19 infection. Clin Infect Dis. 2020;73(1):1&#x2010;11. 10.1093/cid/ciaa1535</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa1535</ArticleId><ArticleId IdType="pmc">PMC7665333</ArticleId><ArticleId IdType="pubmed">33035307</ArticleId></ArticleIdList></Reference><Reference><Citation>Pritchard MG. COVID&#x2010;19 symptoms at hospital admission vary with age and sex: ISARIC multinational study. medRxiv. 2020:2020.2010.2026.20219519.</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Carfi A, Bernabei R, Landi F. Gemelli against C&#x2010;P&#x2010;ACSG. persistent symptoms in patients after acute COVID&#x2010;19. JAMA. 2020;324(6):603&#x2010;605.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Huang L, Wang Y, et al. 6&#x2010;month consequences of COVID&#x2010;19 in patients discharged from hospital: a cohort study. Lancet. 2021;397(10270):220&#x2010;232.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Michelen M, Manoharan L, Elkheir N, et al. Characterising long&#x2010;term covid&#x2010;19: a rapid living systematic review. medRxiv. 2020:2020.2012.2008.20246025.</Citation></Reference><Reference><Citation>Wise J. Long covid: WHO calls on countries to offer patients more rehabilitation. BMJ. 2021;372:n405.</Citation><ArticleIdList><ArticleId IdType="pubmed">33568362</ArticleId></ArticleIdList></Reference><Reference><Citation>Meeting the challenge of long COVID. Nat Med. 2020;26(12):1803. 10.1038/s41591-020-01177-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-01177-6</ArticleId><ArticleId IdType="pubmed">33288947</ArticleId></ArticleIdList></Reference><Reference><Citation>The L. Facing up to long COVID. The Lancet. 2020;396(10266):1861.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7834723</ArticleId><ArticleId IdType="pubmed">33308453</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani D, Khunti K, Nafilyan V, et al. Post&#x2010;covid syndrome in individuals admitted to hospital with covid&#x2010;19: retrospective cohort study. BMJ. 2021;372:n693.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8010267</ArticleId><ArticleId IdType="pubmed">33789877</ArticleId></ArticleIdList></Reference><Reference><Citation>Consortium
. ISARaeI. COVID&#x2010;19 core case report form acute respiratory infection clinical characterisation data tool. 2020; https://isaric.org/wp&#x2010;content/uploads/2020/10/ISARIC_WHO_nCoV_CORE_CRF_25.08.2020.pdf. Accessed 6&#x2010;th of February, 2021.</Citation></Reference><Reference><Citation>The World Health Organization. Global COVID&#x2010;19 Clinical Platform Case Report Form (CRF) for Post COVID condition (Post. COVID&#x2010;19 CRF). 2021; https://www.who.int/publications/i/item/global&#x2010;covid&#x2010;19&#x2010;clinical&#x2010;platform&#x2010;case&#x2010;report&#x2010;form&#x2010;(crf)&#x2010;for&#x2010;post&#x2010;covid&#x2010;conditions&#x2010;(post&#x2010;covid&#x2010;19&#x2010;crf&#x2010;). Accessed 10&#x2010;th of February, 2021.</Citation></Reference><Reference><Citation>Davis HE, Assaf GS, McCorkell L, et al. Characterizing long COVID in an International cohort: 7 months of symptoms and their impact. medRxiv. 2020:2020.2012.2024.20248802.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenhalgh T, Knight M, A'Court C, Buxton M, Husain L. Management of post&#x2010;acute covid&#x2010;19 in primary care. BMJ. 2020;370:m3026.</Citation><ArticleIdList><ArticleId IdType="pubmed">32784198</ArticleId></ArticleIdList></Reference><Reference><Citation>Al&#x2010;Aly Z, Xie Y, Bowe B. High&#x2010;dimensional characterization of post&#x2010;acute sequelae of COVID&#x2010;19. Nature. 2021;594(7862):259&#x2010;264.</Citation><ArticleIdList><ArticleId IdType="pubmed">33887749</ArticleId></ArticleIdList></Reference><Reference><Citation>Augustin M, Schommers P, Stecher M, et al. Post&#x2010;COVID syndrome in non&#x2010;hospitalised patients with COVID&#x2010;19: a longitudinal prospective cohort study. Lancet Reg Health Eur. 2021;6:100122.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8129613</ArticleId><ArticleId IdType="pubmed">34027514</ArticleId></ArticleIdList></Reference><Reference><Citation>Simani L, Ramezani M, Darazam IA, et al. Prevalence and correlates of chronic fatigue syndrome and post&#x2010;traumatic stress disorder after the outbreak of the COVID&#x2010;19. J Neurovirol. 2021;27(1):154&#x2010;159.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7852482</ArticleId><ArticleId IdType="pubmed">33528827</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T, et al. Attributes and predictors of long COVID. Nat Med. 2021;27(4):626&#x2010;631. 10.1038/s41591-021-01292-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Q, Meng M, Kumar R, et al. The impact of COPD and smoking history on the severity of COVID&#x2010;19: A systemic review and meta&#x2010;analysis. J Med Virol. 2020;92(10):1915&#x2010;1921.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7262275</ArticleId><ArticleId IdType="pubmed">32293753</ArticleId></ArticleIdList></Reference><Reference><Citation>Baghai&#x2010;Ravary R, Quint JK, Goldring JJ, Hurst JR, Donaldson GC, Wedzicha JA. Determinants and impact of fatigue in patients with chronic obstructive pulmonary disease. Respir Med. 2009;103(2):216&#x2010;223.</Citation><ArticleIdList><ArticleId IdType="pubmed">19027278</ArticleId></ArticleIdList></Reference><Reference><Citation>Leung JM, Niikura M, Yang CWT, Sin DD. COVID&#x2010;19 and COPD. Eur Respir J. 2020;56(2):2002108.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7424116</ArticleId><ArticleId IdType="pubmed">32817205</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T, et al. Attributes and predictors of Long&#x2010;COVID: analysis of COVID cases and their symptoms collected by the Covid Symptoms Study App. medRxiv. 2010:2020.2010.2019.20214494.</Citation></Reference><Reference><Citation>Avdeev S, Moiseev S, Brovko M, et al. Low prevalence of bronchial asthma and chronic obstructive lung disease among intensive care unit patients with COVID&#x2010;19. Allergy. 2020;75(10):2703&#x2010;2704.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7283669</ArticleId><ArticleId IdType="pubmed">32455491</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferastraoaru D, Hudes G, Jerschow E, et al. Eosinophilia in asthma patients is protective against severe COVID&#x2010;19 illness. J Allergy Clin Immunol Pract. 2021;9(3):1152&#x2010;1162.e3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7826039</ArticleId><ArticleId IdType="pubmed">33495097</ArticleId></ArticleIdList></Reference><Reference><Citation>Afrin LB, Weinstock LB, Molderings GJ. Covid&#x2010;19 hyperinflammation and post&#x2010;Covid&#x2010;19 illness may be rooted in mast cell activation syndrome. Int J Infect Dis. 2020;100:327&#x2010;332.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7529115</ArticleId><ArticleId IdType="pubmed">32920235</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold DT, Hamilton FW, Milne A, et al. Patient outcomes after hospitalisation with COVID&#x2010;19 and implications for follow&#x2010;up: results from a prospective UK cohort. Thorax. 2020;76(4):399&#x2010;401. 10.1136/thoraxjnl-2020-216086</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-216086</ArticleId><ArticleId IdType="pmc">PMC7716340</ArticleId><ArticleId IdType="pubmed">33273026</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>